Musculoskeletal and Neuropathic Pain in COVID-19.
Christopher M LamMiles SandersonDan T VuDawood SayedUsman LatifAndrea L ChadwickPeter S StaatsAbigail YorkGabriella SmithVivek VelagapudiTalal W KhanPublished in: Diagnostics (Basel, Switzerland) (2024)
Chronic pain constitutes a significant disease burden globally and accounts for a substantial portion of healthcare spending. The COVID-19 pandemic contributed to an increase in this burden as patients presented with musculoskeletal or neuropathic pain after contracting COVID-19 or had their chronic pain symptoms exacerbated by the virus. This extensive literature review analyzes the epidemiology of pain pre-pandemic, the costs associated with the COVID-19 pandemic, the impact of the virus on the body, mechanisms of pain, management of chronic pain post-pandemic, and potential treatment options available for people living with chronic pain who have had or are currently infected with COVID-19.
Keyphrases
- chronic pain
- neuropathic pain
- coronavirus disease
- pain management
- sars cov
- spinal cord
- spinal cord injury
- healthcare
- respiratory syndrome coronavirus
- end stage renal disease
- ejection fraction
- newly diagnosed
- risk factors
- chronic kidney disease
- prognostic factors
- case report
- climate change
- risk assessment
- depressive symptoms
- physical activity